Short answer
Clorox (CLX) filed an 8-K current report with the SEC on October 29, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers), Item 7.01 (Regulation FD Disclosure), Item EX-99.1 (Exhibit EX-99.1). Fabian Garcia becomes CEO and director January 5, 2027, bringing Unilever, Revlon and Colgate-Palmolive leadership experience.
Clorox 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.02 · Departure/Election of Directors or Officers
- Fabian Garcia becomes CEO and director January 5, 2027, bringing Unilever, Revlon and Colgate-Palmolive leadership experience
- Linda Rendle exits as CEO, Chair and director, remaining senior advisor through April 2, 2027 at $1,350,000 base salary
- Matthew Shattock becomes independent Chair, receiving an additional $225,000 annual retainer
- Garcia’s package includes $2,000,000 target bonus, $4,550,000 initial long-term award and $11,000,000 sign-on RSUs
- Garcia’s ongoing annual long-term incentive target reaches $9,100,000 beginning September 2027, increasing retention-related compensation exposure
Item 7.01 · Regulation FD Disclosure
- CEO appointment: Mr. Garcia named chief executive officer effective October 29, 2026
- Leadership transition creates potential strategic and execution changes for Clorox
- Exhibit 99.1 contains the company’s full announcement and transition details
Item EX-99.1 · Exhibit EX-99.1
- Fabian Garcia appointed CEO effective January 5, 2027, succeeding Linda Rendle
- Garcia joins Clorox’s board, while Matthew Shattock becomes independent chair
- Rendle exits as CEO and director, remaining an advisor through April 2, 2027
- Leadership transition brings consumer-products experience from Unilever, Revlon, Colgate-Palmolive and Procter & Gamble
- First-quarter fiscal 2027 results scheduled for November 2, before Rendle’s departure
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Clorox 8-K filings
Get the next CLX 8-K as it lands
Follow CLX for push alerts, or ask the research agent what this filing means.